603259: WuXi AppTec Co., Ltd. - Summary | Jitta

WuXi AppTec Co., Ltd.

CHN:603259

Price
CN¥69.42
Loss Chance
44.0%
6.71JITTA SCORE
60.01%Over Jitta Line
Jitta Ranking
41 / 448
281 / 4,778
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (60)
Recent Business Performance (78)
Financial Strength (80)
Return to Shareholders (48)
Competitive Advantage (75)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Operating MarginConsistent
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
SG&A to SalesDecreasing Every Year
CapExVery High
Key Stats
Jitta Score
Jitta Line
6.71
60.01%
4.76
> 1,000%
Life Sciences Tools and Services
3.54
100.00%
7.91
143.93%
7.10
66.48%
COMPANY DESCRIPTION
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People’s Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.